eFFECTOR Therapeutics, Inc. - EFTR

Detailed investor-level table based on 13F positions.
Early Q1 2026 data: only 1 institutional holders reported so far. The full shareholder list will grow as more funds file with the SEC.

Shareholders (13F)

Quarter: Q2 2024 · Compare: Q1 2024
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Alyeska Investment Group, L.P. History New 364,934 105 0.0% 1 +364,934 New Q2 2024 Aug 14, 2024
Carlyle Group Inc. History No change 192,884 55 0.01% 0.17% 2 0 0.0% Q2 2024 Aug 09, 2024
UBS Group AG History New 61,667 17 0.0% 3 +61,667 New Q2 2024 Aug 14, 2024
VANGUARD GROUP INC History Reduced 25,070 7 0.0% 0.0% 4 -67,395 -72.89% Q2 2024 Aug 13, 2024
GEODE CAPITAL MANAGEMENT, LLC History Added to 25,583 7 0.0% 0.0% 5 +2,974 13.15% Q2 2024 Aug 09, 2024
JANE STREET GROUP, LLC History New 18,669 5 0.0% 6 +18,669 New Q2 2024 Aug 15, 2024
TWO SIGMA INVESTMENTS, LP History New 11,115 3 0.0% 7 +11,115 New Q2 2024 Aug 14, 2024
Tower Research Capital LLC (TRC) History Added to 9,805 2 0.0% 0.0% 8 +8,271 539.18% Q2 2024 Aug 13, 2024
ARMISTICE CAPITAL, LLC History Closed out 0 0 0.04% -223,000 -100.0% Q1 2024 May 15, 2024
Ensign Peak Advisors, Inc History Closed out 0 0 0.0% -32,945 -100.0% Q1 2024 May 14, 2024
MORGAN STANLEY History Reduced 240 0 0.0% -1,375 -85.14% Q2 2024 May 14, 2025
ROYAL BANK OF CANADA History Added to 546 0 0.0% +114 26.39% Q2 2024 Nov 06, 2024
BARCLAYS PLC History New 100 0 +100 New Q2 2024 Mar 23, 2026
BANK OF AMERICA CORP /DE/ History New 31 0 +31 New Q2 2024 Aug 14, 2024
WELLS FARGO & COMPANY/MN History Closed out 0 0 -19 -100.0% Q1 2024 May 10, 2024
Qube Research & Technologies Ltd History No change 3 0 0 0.0% Q2 2024 Aug 14, 2024